Search

Author/Creator Nakano, Aiko

1. Comparisons between tumor burden and other prognostic factors that influence survival of patients with non‐small cell lung cancer treated with immune checkpoint inhibitors. Issue 12 (3rd November 2019)

Authors:
Sakata, Yoshihiko; Kawamura, Kodai; Ichikado, Kazuya; Shingu, Naoki; Yasuda, Yuko; Eguchi, Yoshitomo; Hisanaga, Jumpei; Nitawaki, Tatsuya; Iio, Miwa; Sekido, Yuko; Nakano, Aiko; Sakagami, Takuro
Journal:
Thoracic cancer
Issue:
Volume 10:Issue 12(2019)
Page Start:
2259
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. The association between tumor burden and severe immune-related adverse events in non-small cell lung cancer patients responding to immune-checkpoint inhibitor treatment. (April 2019)

Authors:
Sakata, Yoshihiko; Kawamura, Kodai; Ichikado, Kazuya; Shingu, Naoki; Yasuda, Yuko; Eguchi, Yoshitomo; Anan, Keisuke; Hisanaga, Junpei; Nitawaki, Tatsuya; Iio, Miwa; Sekido, Yuko; Nakano, Aiko; Sakagami, Takuro
Journal:
Lung cancer
Issue:
Volume 130(2019)
Page Start:
159
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. The effects of switching EGFR‐TKI treatments for non‐small cell lung cancer because of adverse events. Issue 2 (2nd December 2018)

Authors:
Sakata, Yoshihiko; Kawamura, Kodai; Shingu, Naoki; Hiroshige, Shigeo; Yasuda, Yuko; Eguchi, Yoshitomo; Anan, Keisuke; Hisanaga, Junpei; Nitawaki, Tatsuya; Nakano, Aiko; Ichikado, Kazuya
Journal:
Asia-Pacific journal of clinical oncology
Issue:
Volume 16:Issue 2(2020)
Page Start:
e113
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗